Intra-Cellular Therapies (ITCI) Stock Highlights

83.45 | -0.82%

2024-12-21 01:19:31

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The companys business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Statistics

Range Today

82.77 85.03

Volume Today 924.12K

Range 1 Year

62.78 93.45

Volume 1 Year 208.32M

Range 3 Year

38.51 93.45

Volume 3 Year 627.71M

Range 10 Year

6.75 93.45

Volume 10 Year 1.9B

Highlights

Market Capitalization 9.68B (mid)

Floating Shares 103.74M

Current Price 83.45

Price To Earnings -102.95

Price To Revenue 14.02

Price To Book 8.45

Earnings Per Share -0.87

Payout Ratio 0%

Performance

Latest -0.82%

1 Month +0.12%

3 Months +8.38%

6 Months +10.93%

1 Year +28.19%

3 Years +90.26%

5 Years +563.88%

10 Years +400%

Benchmarks

Market Capitalization

27 / 368

Gross Profits

47 / 278

Total Revenue

26 / 300

Total Rank

165 / 368

Free Cashflow

291 / 352

Performance 5 years

12 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.